Patents by Inventor Manola Moretti

Manola Moretti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide-based Dopa containing adhesive gels
    Patent number: 12116421
    Abstract: The present disclosure relates to Dopa containing ultrashort peptides capable of forming a gel, to a gel comprising a peptide in accordance with the present disclosure, and to a glue comprising a peptide in accordance with the present disclosure. Such gel is adhesive and is biocompatible. The peptides are suitable for building 3D structures, 3D printing, gluing as well as other applications.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: October 15, 2024
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Charlotte A. E. Hauser, Maria Hountondji, Manola Moretti, Panagiotis Bilalis
  • Developing lateral flow immunochromatography (LFIA) peptide-based test strips for rapid detection of antigens and antibodies against specific antigens
    Patent number: 11994520
    Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: May 28, 2024
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Charlotte A. E. Hauser, Panagiotis Bilalis, Dana Alhattab, Hepi Hari Susapto, Manola Moretti, Salwa Alshehri, Ali Aldoukhi, Hamed Albalawi, Hattan Boshah, Abdulelah Alrashoudi, Alexander Valle Perez, Rosario Perez Pedroza
  • DEVELOPING LATERAL FLOW IMMUNOCHROMATOGRAPHY (LFIA) PEPTIDE-BASED TEST STRIPS FOR RAPID DETECTION OF ANTIGENS AND ANTIBODIES AGAINST SPECIFIC ANTIGENS
    Publication number: 20230408518
    Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
    Type: Application
    Filed: November 22, 2021
    Publication date: December 21, 2023
    Inventors: Charlotte A.E. Hauser, Panagiotis Bilalis, Dana Alhattab, Hepi Hari Susapto, Manola Moretti, Salwa Alshehri, Ali Aldoukhi, Hamed Albalawi, Hattan Boshah, Abdulelah Alrashoud, Alexander Valle Perez, Rosario Perez Pedroza
  • PEPTIDE-BASED DOPA CONTAINING ADHESIVE GELS
    Publication number: 20230374069
    Abstract: The present disclosure relates to Dopa containing ultrashort peptides capable of forming a gel, to a gel comprising a peptide in accordance with the present disclosure, and to a glue comprising a peptide in accordance with the present disclosure. Such gel is adhesive and is biocompatible. The peptides are suitable for building 3D structures, 3D printing, gluing as well as other applications.
    Type: Application
    Filed: September 2, 2021
    Publication date: November 23, 2023
    Inventors: Charlotte A.E. Hauser, Maria Hountondji, Manola Moretti, Panagiotis Bilalis